Today on Drug Discovery & Development
Six leading medical organizations sue RFK Jr. over vaccine recommendations
Several leading medical organizations filed a lawsuit against Robert F. Kennedy Jr. on Monday, claiming that recent decisions to stop recommending vaccines to pregnant women and children are unscientific and harmful to the public. The suit was filed in the U.S. District Court for the District of Massachusetts. The American Public Health Association (APHA), the…
NIH announces end to funding for animal-only studies
The National Institutes of Health announced on Monday that the biomedical agency would no longer award funding to new grant proposals solely relying on animal testing. The policy was unveiled at the FDA & NIH Workshop on Reducing Animal Testing in comments from Dr. Nicole Kleinstreuer, Acting NIH Deputy Director for Program Coordination, Planning and…
Drug Discovery and Development See More >
How a ‘rising tide’ of inclusivity is transforming clinical trials
Let’s say there’s a Black female patient with an aggressive form of breast cancer. She meets with her oncologist to discuss a promising targeted therapy that recently won FDA approval. The drug showed strong efficacy in clinical trials, with a 65% response rate. Yet when she asks about efficacy data specific to Black women, she…
Mary Marcus appointed CEO of NewAge Industries
Biotech in 2025: Precision medicine, smarter investments, and more emphasis on RWD in clinical trials
External comparator studies: What researchers need to know to minimize bias
Tiny breaths, big impacts: Bridging the gap between laboratory discoveries and clinical applications in breath research with mouse models
Sponsored Content See More >
Complexity’s counterpoint: Understanding protocol optimization In recent years, the clinical research landscape has been marked by a steady rise in protocol complexity with more endpoints…
Optimizing Data Pipelines in Life Sciences with AI-Driven Integration and FHIRSponsored by Infor. Data management in life sciences is inherently complex. Data is fragmented across multiple systems — such…
Accelerating life sciences with AI This case study is sponsored by Infor. Artificial intelligence can revolutionize clinical interoperability by building bridges across data silos. Machine…
Advancing Clinical Trials and ResearchThis case study is sponsored by Infor. In the complex landscape of clinical trials and medical research, data fragmentation remains…
Multidisciplinary approaches optimize contract drug discovery
5 Key Questions in Conducting Global Usability StudiesBy Dr Bryce G Rutter, Head Noble Consulting Services Evaluating device usability throughout the product development process is crucial. A…
Leveraging HF/UX/ID Services to Optimize the Design of Combination Devices for Arthritic HandsBy Dr. Bryce G Rutter, Head of Consulting Services Arthritis changes how people grasp and manipulate an object, reducing the…
Ask the Expert: Navigating the New FDA Rules on Laboratory Developed Tests (LDTs)The U.S. FDA released a final rule to regulate laboratory developed tests (LDTs) on May 6, 2024, making it clear…
How tailored qPCR assays can unlock microbiome and precision medicine potential Sponsored by Diversigen, Inc. Quantitative Polymerase Chain Reaction (qPCR) — also known as real-time PCR — is a molecular…
Innovations in Baculovirus–Insect Cell Expression SystemsThe baculovirus–insect cell expression system—insect cells used in conjunction with the baculovirus expression vector system (BEVS)—remains a crucial technology for…
Patient Training is Broken – And Everyone is Paying For ItNoble International is working with Pharma and Specialty Pharmacy to fix the problem. The report, “The Current Paradigm for Biologic…
Noble Leads with its User-Centered Design StrategyBy Tim McLeroy, Executive Director of Marketing and Patient Services, Noble International At Noble, the patient journey drives everything we…
Genomics/Proteomics See More >
Spatial biology: Transforming our understanding of cellular environments
Spatial biology is revolutionizing our understanding of how cells interact with their natural environments. Although that may sound like an overstatement, it isn’t. Spatial biology involves the use of advanced imaging and molecular techniques to visualize and map the location of cells, transcripts, proteins and their interactions within tissues. Traditional biological studies have long focused…
Biotech in 2025: Precision medicine, smarter investments, and more emphasis on RWD in clinical trials
Genomics in 2025: How $500 whole genome sequencing could democratize genomic data
St. Jude pioneers gene editing and structural biology to advance pediatric research
![A display of DNA sequencing output from an automated ABI 373 sequencer. [National Human Genome Research Institute (NHGRI)]](https://www.drugdiscoverytrends.com/wp-content/uploads/2024/06/51187236177_b7b566a401_k-268x170.jpg)
Helix and Recursion join forces in quest to crack the AI-driven drug discovery code
Infectious Disease See More >
Six leading medical organizations sue RFK Jr. over vaccine recommendations
Several leading medical organizations filed a lawsuit against Robert F. Kennedy Jr. on Monday, claiming that recent decisions to stop recommending vaccines to pregnant women and children are unscientific and harmful to the public. The suit was filed in the U.S. District Court for the District of Massachusetts. The American Public Health Association (APHA), the…
RFK’s new ACIP changed longstanding vaccine recommendations
Secretary of Health removes all current members of the CDC advisory committee on immunization practices
FDA COVID booster pullback jolts vaccine stocks before gains cool
Pregnancy associated with less long COVID: Researchers call for studies on protective biology
Oncology See More >
New treatment paradigms in oncology: Highlights from the ASCO 2025 annual meeting
As in previous years, the 2025 ASCO Annual Meeting showcased a strong portfolio of practice-changing data across a wide range of tumor types. Combination therapies remain a central theme, continuing to drive meaningful improvements in clinical outcomes. These benefits are increasingly balanced by evolving strategies for managing adverse events, underscoring the field’s commitment to both…
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
As some biotechs cut, Genmab unveils striking new site near Princeton
OS Therapies announces favorable FDA feedback on external control arm strategy for osteosarcoma drug
